What's Hot
View all perspectives
Staying on Therapy in RA: Dr. Janet Pope
Dr. Janet Pope reviews abstract #0804 - Factors That Influence Biological Survival in Rheumatoid Arthritis: Results of a Real-world Cohort from the Netherlands- presented at the ACR 2020 annual meeting.
Eric Dein ejdein1
4 years ago
Dr. Subedi: "we need to stop blaming just the age" in geriatric patients for adherence. Busy, middle aged patients more likely than geriatrics to have adherence issues. 3S040. Pharmaco Pearls for Older Rheum Pt. #ACR20 @RheumNow https://t.co/3UAkjRNT3u
Richard Conway RichardPAConway
4 years ago
Dr Merriman presents on role of diet in gout. It is minor, especially compared to urate lowering therapy. Average attributable fraction approximately 10-fold greater for ULT than following healthy-eating guidelines. @rheumnow #ACR20 Abstr#951 https://t.co/1tftswOEJq
Mrinalini Dey DrMiniDey
4 years ago
Time-trend analysis in hospitalised #infection in #lupus
-Incr. rate of hospitalised infections over time
-#Sepsis surpassed #pneumonia as most common hospitalised infection in 2011-12; twice as many sepsis vs pneumonia by 2015-16
Abs#0980 #ACR20 @RheumNow
https://t.co/M8xbMDFUTS https://t.co/ShogvxbhzN
Richard Conway RichardPAConway
4 years ago
Dr Cai presents risk of CVD in gout in study 450,000 patients. Gout was independently associated with an increased risk of CVD events HR = 1.24 for women; 1.21 for men. @rheumnow #ACR20 Abstr#950 #ACRbest https://t.co/089aKtN5a7
Another great way to get highlights from the ACR 2020 meeting - listen in to faculty reports and overviews.
Click here to listen.
Treat to Target in Spondyloarthritis: Dr. Rachel Tate
Dr. Tate discusses abstracts #0879, #0893 and #1892 presented at the ACR20 annual meeting.
Another great way to get highlights from the ACR 2020 meeting - listen in to faculty reports and overviews.
Click here to listen
Robert B Chao, MD doctorRBC
4 years ago
Racial disparity in SSc-ILD pts treated with MMF?
1️⃣Early initiation of MMF significantly slowed ⬇️ of FVC%
2️⃣No difference in MMF efficacy between African-Americans and non-AA
3️⃣AA had baseline lower FVC%
@RheumNow #ACR20 Abs0929 https://t.co/rtsbe7OCvA
Olga Petryna DrPetryna
4 years ago
@RheumNow #acr20 abs0876 gender differences AS and nrSpA from 3 RCT IXE trials: F more likely to be older, have more nocturnal BP, peripheral pain&fatigue. M have higher CRP & +HLAB27. Ant uveitis > in M w/AS (23.8% vs. 17.9%) but > common in F w/ nr-axSpA (15.2% vs. 7.1%). https://t.co/HZa7AfWbBh
Dr. John Cush RheumNow
4 years ago
The RheumNow podcast on #ACR20 Day 1 Part II is now available for download. Follow the link below to listen in or find us on Apple.
https://t.co/W6EMQiF9Rf https://t.co/ZlFDiVgAKl
k dao KDAO2011
4 years ago
Dr Fauci assured the medical community the NIH #COVID19 reccs can be trusted and is a living document that we should access to care for patients with CV19 #ACR20 @RheumNow https://t.co/GrJUvdFFhk
sheila RHEUMarampa
4 years ago
Such an honor to have @DrFaucis1 at #ACR20! 👏👏👏 He reminds us of the fundamentals to prevent acquiring and transmitting #SARSCoV2 @RheumNow https://t.co/Xu4F8q64RJ
At #ACR20 three different medications are reviewed in different studies to decrease the immunogenicity of pegloticase – Methotrexate, Azathioprine and Mycophenolate Mofetil.
Meral K. El Ramahi, MD MeralElRamahiMD
4 years ago
Dr. Anthony Fauci’s session has been of the most popular lectures at #ACR20! Checkout highlights from his talk below!
@RheumNow https://t.co/720LUTIncJ
Poster Hall